Magnesium and Zinc in Schizophrenia
1Department of Pharmacology, Gr. T Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
Magnesium and zinc play crucial roles in schizophrenia by influencing neurotransmitter systems and other factors. Correcting deficiencies in these essential minerals is vital for managing schizophrenia.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Schizophrenia is a severe, chronic mental disorder with complex genetic and epigenetic underpinnings.
- The roles of magnesium and zinc in schizophrenia pathogenesis are often underestimated.
- These minerals influence critical neurotransmitter systems and various other factors implicated in the disease.
Purpose of the Study:
- To explore the understudied involvement of magnesium and zinc in schizophrenia.
- To elucidate the mechanisms through which these cations affect schizophrenia.
- To highlight the importance of assessing and correcting magnesium and zinc levels in patients.
Main Methods:
- Review of existing literature on magnesium, zinc, and schizophrenia.
- Analysis of the influence of these cations on neurotransmitter systems (dopaminergic, glutamatergic, etc.).
- Examination of interactions with other pathogenic factors and medications.
Main Results:
- Magnesium and zinc significantly impact neurotransmitter systems in the brain.
- These cations modulate neuroinflammation, oxidative stress, and levels of factors like BDNF and galanin.
- Deficiencies in magnesium and zinc are linked to schizophrenia and may affect medication efficacy and physiological processes like sleep and appetite.
Conclusions:
- Magnesium and zinc are critical, yet often overlooked, factors in schizophrenia.
- Determining and correcting magnesium and zinc levels should be a standard part of patient care.
- Addressing these deficiencies may improve treatment outcomes for schizophrenia.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Mania and Antimanic Drugs: Overview
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychological and Sociocultural Causes of Schizophrenia
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
